You are here

Article info

Article menu
Download PDFPDF
ORIGINAL ARTICLE
Topotecan in heavily pretreated patients with recurrent ovarian, peritoneal, and fallopian tube carcinoma

Authors

  • B. Piura Unit of Gynecologic Oncology, Department of Obstetrics and Gynecology, Soroka Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel PubMed articlesGoogle scholar articles
  • A. Rabinovich Unit of Gynecologic Oncology, Department of Obstetrics and Gynecology, Soroka Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel PubMed articlesGoogle scholar articles
  1. Address correspondence and reprint requests to: Benjamin Piura, MD, FRCOG, Unit of Gynecologic Oncology, Department of Obstetrics and Gynecology, Soroka Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, P.O. Box 151, Beer-Sheva 84101, Israel. Email: piura{at}bgumail.bgu.ac.il

Citation

Piura B, Rabinovich A
Topotecan in heavily pretreated patients with recurrent ovarian, peritoneal, and fallopian tube carcinoma
International Journal of Gynecologic Cancer 2005;15:612-617.

Publication history

  • First published June 1, 2005.
Online issue publication 
June 01, 2005

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright © 2005 Blackwell Publishing Ltd.